Urgent.News

600+ sources. One page. See who else covered it.

Editions

Culture

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.

Read the original at marketwatch.com →

More in Culture

More from Wednesday 5 August →